A

Apellis Pharmaceuticals

APLS

36.005
USD
-3.615
(-9.12%)
مغلق
حجم التداول
56,989
الربح لكل سهم
0
العائد الربحي
0
P/E
-10
حجم السوق
3,359,532,990
أصول ذات صلة
ABBV
4.380
(2.36%)
189.700 USD
K
KALV
-0.700
(-4.81%)
13.840 USD
LLY
28.47
(3.54%)
832.74 USD
MRK
0.680
(0.60%)
113.800 USD
NVS
0.650
(0.58%)
112.100 USD
REGN
13.14
(1.22%)
1,091.19 USD
S
SLNO
0.870
(1.80%)
49.320 USD
الأخبار المقالات

العنوان: Apellis Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.